ActiveMSers Forums  

Go Back   ActiveMSers Forums > ActiveMSers.org Forums > General

Reply
 
Thread Tools Display Modes
  #1  
Old 05-28-2019, 01:02 PM
ActiveMSers's Avatar
ActiveMSers ActiveMSers is offline
Dave @ ActiveMSers
 
Join Date: Jun 2008
Location: Albuquerque, NM
Posts: 3,723
Default Effect of omega-3 supplementation on EDSS and Inflammatory Cytokines in MS

Effect of omega-3 supplementation on Expanded Disability Status Scale and Inflammatory Cytokines in multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials.

(PMID:31096898)
Abstract

Sedighian M, et al
CNS & Neurological Disorders Drug Targets [15 May 2019]
Type: Journal Article
DOI: 10.2174/1871527318666190516083008

Abstract

Recent trial studies have shown that omega-3 supplementation can beneficially improve Expanded Disability Status Scale (EDSS) which considered as a gold standard for measuring disability and disease severity in multiple sclerosis (MS) patients as well as reducing neuroinflammation. The present systematic review and meta-analysis aimed to evaluate the effect of omega-3 supplementation on EDSS and cytokines in MS.

We performed a systematically search on Pubmed, Scopus and Cochrane Library up to October 2018. Studies were reviewed based on Cochrane handbook and preferred reporting items for systematic reviews and meta-analyses (PRISMA).

Weighted mean difference (WMD) with 95% confidence intervals (CI) were pooled using random effects model in order to compare the effects of omega-3 with placebo. Among 4 trials, omega3 supplementation had no significant effect on EDSS scale (WMD: -0.07; 95% CI: -0.27 to 0.13; P=0.50) as well as serum levels of IL-1β (WMD: -7.67; 95% CI: -23.31 to 7.97; P=0.34) and IL-6 (WMD: -153.57; 95% CI: -455.36 to 148.23; P=0.32) but omega-3 significantly reduce TNF-α concentration (WMD: -16.76; 95% CI: -18.63 to -14.88; P < 0.00001) compared to placebo.

Overall, omega-3 supplementation may not have clinically considerable impact on EDSS or proinflammatory markers. However the trials are limit in this context and further clinical trials are required to confirm the potential effect of omega-3 supplement on MS disease management.
__________________
Dave Bexfield
ActiveMSers
Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump


All times are GMT -4. The time now is 04:13 PM.


Powered by vBulletin® Version 3.7.0
Copyright ©2000 - 2019, Jelsoft Enterprises Ltd.
ActiveMSers